The antiproteinuric effect of CPAP in chronic kidney disease patients complicated with obstructive sleep apnea

The antiproteinuric effect of CPAP in chronic kidney disease patients complicated with obstructive sleep apnea - Effect of CPAP in chronic kidney disease complicated with obstructive sleep apnea

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000002904

Enrollment

Registered

2009-12-18

Start date

2009-10-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-dialysis chronic kidney disease obstructive sleep apnea

Interventions

CPAP group: eight-week treatment of continuous positive airway pressure (CPAP) Control group: Patients who reject continuous positive airway pressure (CPAP) treatment.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Non-dialysis chronic kidney disease patients who are diagnosed with obstructive sleep apnea by polysomnography. Apnea-hypopnea index is 20 or more.

Exclusion criteria

Exclusion criteria: 1)Patients with proteinuria less than 0.5g/day 2)Patients with severe complications or active infection 3)Patients with rapidly deteriorated renal function

Design outcomes

Primary

Measure	Time frame
Comparison with urinary protein before and after 8-week therapy with CPAP	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026